 "Over 200 BSE-500 stocks under-perform since August")
As the markets remain in a consolidation mode after the S&P BSE Sensex fell 2.6% (873 points) from its closing high of 32,575, hit on August 1, 2017, there are over 200 stocks in the BSE500 index that underperformed the indices and fell up to 58% during this period. Meanwhile, Nifty50 index also cracked 1.9% (201 points) from its closing high of 10,114.
Poor earnings, geopolitical concerns over North Korea missile tests, India-China Doklam stand-off were few of the main reasons behind the fall in the indices.
Sectorally, pharma index was the biggest loser with BSE Healthcare and Nifty Pharma down 6.2% and 4.6% respectively, during the period after number of class action lawsuits filed against Indian pharmaceutical companies increased in the recent times. Natco Pharma, Ajanta Pharma, Ipca Laboratories, Glenmark Pharmaceuticals, Apollo Hospitals Enterprise and Biocon were few of the top losers in the BSE500.
Among the laggards, Religare Enterprises, J Kumar Infraprojects, Natco Pharma, Housing Development & Infrastructure (HDIL), Videocon Industries, Kwality and Kaveri Seed Company fell between 20-55% on BSE500.
Religare Enterprises cracked 58% since August 1 to its 52-week low of Rs 42.70. Recently, the firm announced that its standalone net loss has widened to Rs 47.39 crore for the first quarter ended June 30, 2017. The company had registered a net loss of Rs 25.84 crore in the same quarter of 2016-17.
Among other stocks, Videocon, with market capitalisation of Rs. 610 crore and outstanding debt of Rs. 43,000 crore, tanked 22% during the period. The company has has initiated talks with its lenders to restructure its debts by September to avoid going into bankruptcy proceedings at the National Company Law Tribunal (NCLT). The company is learnt to have got in-principle approval of lenders to restructure debts after its promoters agreed to pump in Rs. 3,000 crore as equity.
Bank of Baroda fell over 16% after lender’s first quarter earnings missed analysts' estimates. Profit fell 52% to Rs 203.4 crore compared with same quarter last year. It was impacted by higher provisions and tepid net interest income & non-interest income growth. Net interest income during the quarter increased 1% year-on-year to Rs 3,405 crore, with loan growth of 4% Rs 3.77 lakh crore.
Here’s a list of the top 15 losers on BSE500:
Poor earnings, geopolitical concerns over North Korea missile tests, India-China Doklam stand-off were few of the main reasons behind the fall in the indices.
Sectorally, pharma index was the biggest loser with BSE Healthcare and Nifty Pharma down 6.2% and 4.6% respectively, during the period after number of class action lawsuits filed against Indian pharmaceutical companies increased in the recent times. Natco Pharma, Ajanta Pharma, Ipca Laboratories, Glenmark Pharmaceuticals, Apollo Hospitals Enterprise and Biocon were few of the top losers in the BSE500.
Among the laggards, Religare Enterprises, J Kumar Infraprojects, Natco Pharma, Housing Development & Infrastructure (HDIL), Videocon Industries, Kwality and Kaveri Seed Company fell between 20-55% on BSE500.
Religare Enterprises cracked 58% since August 1 to its 52-week low of Rs 42.70. Recently, the firm announced that its standalone net loss has widened to Rs 47.39 crore for the first quarter ended June 30, 2017. The company had registered a net loss of Rs 25.84 crore in the same quarter of 2016-17.
Among other stocks, Videocon, with market capitalisation of Rs. 610 crore and outstanding debt of Rs. 43,000 crore, tanked 22% during the period. The company has has initiated talks with its lenders to restructure its debts by September to avoid going into bankruptcy proceedings at the National Company Law Tribunal (NCLT). The company is learnt to have got in-principle approval of lenders to restructure debts after its promoters agreed to pump in Rs. 3,000 crore as equity.
Bank of Baroda fell over 16% after lender’s first quarter earnings missed analysts' estimates. Profit fell 52% to Rs 203.4 crore compared with same quarter last year. It was impacted by higher provisions and tepid net interest income & non-interest income growth. Net interest income during the quarter increased 1% year-on-year to Rs 3,405 crore, with loan growth of 4% Rs 3.77 lakh crore.
Here’s a list of the top 15 losers on BSE500:
| Stock Price(Rs) | |||
|---|---|---|---|
| Company Name | 1-Aug-17 | 4-Sep-17 | % change |
| Religare Enterprises Ltd. | 104.00 | 43.35 | -58.32 |
| J Kumar Infraproject Ltd. | 294.00 | 189.65 | -35.49 |
| Natco Pharma Ltd. | 967.00 | 704.70 | -27.13 |
| Housing Development & Infrastructure Ltd. | 85.35 | 62.30 | -27.01 |
| Videocon Industries Ltd. | 23.65 | 18.30 | -22.62 |
| Kwality Ltd. | 143.60 | 114.25 | -20.44 |
| Kaveri Seed Company Ltd. | 682.20 | 543.30 | -20.36 |
| Indo Count Industries Ltd. | 143.40 | 114.30 | -20.29 |
| Gateway Distriparks Ltd. | 271.75 | 221.95 | -18.33 |
| Nilkamal Ltd. | 1871.80 | 1546.65 | -17.37 |
| JBF Industries Ltd. | 213.10 | 177.45 | -16.73 |
| Bank Of Baroda | 163.15 | 136.75 | -16.18 |
| Jaiprakash Associates Ltd. | 28.45 | 23.85 | -16.17 |
| SML Isuzu Ltd. | 1118.75 | 942.20 | -15.78 |
| Repco Home Finance Ltd. | 759.05 | 647.05 | -14.76 |
| Source: Ace Equity | |||
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%